///////////////////////////////////////////////////////////
INTELLIGENT VERTICAL: HEALTHCARE
BENEVOLENTAI
ACQUIRES RESEARCH
FACILITY TO ACCELERATE
AI DRUG DEVELOPMENT
Information technology is now capable of offering healthcare
services first-hand. Artificial intelligence (AI) is more intelligent than
you might have first thought; in fact, AI, along with smartphone
apps, are now contributing largely to healthcare innovation by
providing advancements in patient treatment, clinical
developments and efficiency of health services.
B
enevolentAI, one of the world’s largest
private AI companies, has announced
that it has acquired a state-of-the-art
drug discovery and development facility
on the Babraham Research Campus in
Cambridge (UK) for an undisclosed sum.
The acquisition creates a unique AI-enabled
research centre that can radically reduce
the time it takes for drug candidates
to enter clinical testing and deliver
significantly higher success rates in treating
or curing disease.
The acquisition marks the first time an AI
company will be able to work across the
entire drug development process ‘end-
to-end’ from drug discovery to late stage
clinical development.
www.intelligentcio.com
The acquired drug discovery and
development facility has a large scientific
team with deep expertise in assay
development and screening, medicinal and
synthetic chemistry, drug metabolism and
pharmacokinetics, pharmacology and clinical
development. The Cambridge team will
integrate with BenevolentAI’s world class
drug discovery scientists, using AI to rapidly
advance the right drugs to the right patients.
BenevolentAI’s artificial intelligence
technology has successfully generated novel
drug candidates to treat a range of complex
and previously untreatable diseases. The
company has rapidly expanded its drug
research pipeline to include 19 programmes
since establishing its drug development
subsidiary, BenevolentBio, less than two years
“
WE HAVE BUILT
AN ARTIFICIAL
INTELLIGENCE
TECHNOLOGY
THAT CAN
READ AND
UNDERSTAND
THE WORLD’S
BIOMEDICAL
INFORMATION.
INTELLIGENTCIO
95